LUMASIRAN

LUMASIRAN (15052F)

Lumasiran 94.5 mg/0.5 mL injection, 0.5 mL vial
15052F
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Primary hyperoxaluria type 1
Treatment phase: Initial treatment - loading dose
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 5 Max qty units: 5 # of repeats: 2 DPMQ: $490,095.78 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Oxlumo

LUMASIRAN (15060P)

Lumasiran 94.5 mg/0.5 mL injection, 0.5 mL vial
15060P
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Primary hyperoxaluria type 1
Treatment phase: Continuing treatment

Restriction

Indication: Primary hyperoxaluria type 1
Treatment phase: Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 5 Max qty units: 5 # of repeats: 1 DPMQ: $490,095.78 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Oxlumo